|
Market Closed -
Nasdaq
04:00:00 2026-09-16 pm EDT
|
5-day change | 1st Jan Change | ||
| 77.64 USD | -0.75% |
|
-6.20% | -5.18% |
| Market Cap | 3.43B 2.98B 2.81B 2.55B 4.78B 329B 4.81B 33.57B 12.97B 167B 12.9B 12.61B 532B | P/E 2026 * |
-36.7x | P/E 2027 * | 33.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.43B 2.98B 2.81B 2.55B 4.78B 329B 4.81B 33.57B 12.97B 167B 12.9B 12.61B 532B | EV / Sales 2026 * |
4.8x | EV / Sales 2027 * | 3.77x |
| Free-Float |
97.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TARS | Delayed | |
CBOE
| TARS | Real-time |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | -0.75% | ||
| 1 week | -6.20% | ||
| Current month | +4.58% | ||
| 1 month | +9.95% | ||
| 3 months | +27.70% | ||
| 6 months | +12.69% | ||
| Current year | -5.18% |
| 1 week | 77.08 |  | 83.34 |
| 1 month | 68.71 | | 91.53 |
| Current year | 53.89 | | 91.53 |
| 1 year | 50.71 | | 91.53 |
| 3 years | 12.57 | | 91.53 |
| 5 years | 10.8 | | 91.53 |
| 10 years | 10.8 | | 91.53 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 2018-08-31 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 2023-04-23 |
| Chief Tech/Sci/R&D Officer | 47 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 2022-12-01 |
| Director/Board Member | 71 | 2019-11-30 | |
Bill Link
BRD | Director/Board Member | 80 | 2016-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/4/26 | Sell | Chief Operating Officer | -4,564 | 0.0104% | ||
| 9/4/26 | Sell | Chief Executive Officer | -10,000 | 0.0228% | ||
| 9/4/26 | Sell | Chief Technology Officer | -13,953 | 0.0318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.75% | -6.20% | +53.44% | +369.12% | 3.43B | |
| +0.06% | -4.09% | +34.70% | -6.05% | 77.3B | |
| +0.09% | -0.22% | -14.71% | -34.84% | 59.52B | |
| +1.29% | +7.38% | +486.23% | +39.83% | 57.4B | |
| -0.21% | -2.15% | -11.88% | +25.36% | 47.91B | |
| -1.81% | -0.39% | +0.29% | +144.77% | 46.2B | |
| -0.07% | +2.51% | +50.34% | -14.72% | 31.94B | |
| +2.47% | -1.00% | +48.69% | +109.63% | 24.68B | |
| -0.95% | -6.09% | -1.57% | +140.05% | 21.08B | |
| -0.05% | -3.85% | +60.95% | +95.99% | 15.65B | |
| Average | +0.07% | -1.96% | +70.65% | +86.91% | 38.51B | |
| Weighted average by Cap. | +0.17% | -0.98% | +85.88% | +40.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 715M 619M 586M 532M 996M 68.58B 1B 6.99B 2.7B 34.78B 2.69B 2.63B 111B | 910M 789M 746M 677M 1.27B 87.32B 1.28B 8.9B 3.44B 44.29B 3.42B 3.34B 141B |
| Net income | -95.74M -82.97M -78.42M -71.19M -133M -9.18B -134M -936M -362M -4.66B -360M -352M -14.85B | 116M 100M 94.95M 86.2M 162M 11.12B 163M 1.13B 438M 5.64B 435M 426M 17.98B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-16 | $77.64 | -0.75% | 658,224 |
| 26-09-15 | $78.23 | -2.15% | 623,985 |
| 26-09-14 | $79.95 | +0.81% | 693,703 |
| 26-09-11 | $79.31 | -2.23% | 490,786 |
| 26-09-10 | $81.12 | -1.99% | 403,284 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
